Our Partner Pharmacies
Healthcare Providers: For additional information on how to submit your prescription, visit the pharmacy website listed below.
Patients: Find your pharmacy below by following the link to the website.
Pharmacies: Revelation Pharma is looking for credible and reputable compounding pharmacies who want to collaborate and grow.
Everwell
Selling owner: Chris Schulte
Location: Pensacola, FL
Partnership Date: December 2020
Website: Click Here
Innovation Compounding
Selling owner: Shawn Hodges
Location: Kennesaw, GA
Partnership Date: December 2021
Website: Click Here
Eastern States Compounding Pharmacy
Selling owner: David Rochefort
Location: Littleton, NH
Partnership Date: February 2022
Website: Click Here
Pencol Compounding Pharmacy
Selling owner: Tony Jones
Location: Denver, CO
Partnership Date: August 2021
Website: Click Here
Pharmacy Specialists
Selling owner: Sam Pratt
Location: Altamonte Springs, FL
Partnership Date: April 2021
Website: Click Here
Selling owner: Tom Schnorr
Location: Austin, TX
Partnership Date: July 2022
Website: Click Here
South River Compounding Pharmacy
Selling owner: Baylor Rice
Location: Midlothian, VA & Richmond, VA
Partnership Date: August 2022
Website: Click Here
Community Clinical Pharmacy
Selling owner: Kris Kaniski PharmD.
Location: Meza, AZ
Partnership Date: November 2022
Website: Click Here
Makers Compounding Pharmacy
Selling owner: Michelle Moser, RPh.
Location: Mount Vernon, WA
Partnership Date: January 2023
Website: Click Here
Rock Valley Compounding Pharmacy
Selling owner: Jon Lehan, RPh.
Location: Rockford, IL
Partnership Date: March 2023
Website: Click Here
Stanley Specialty Pharmacy
Selling owner: Doug Yoch, RPh.
Location: Charlotte, NC
Partnership Date: February 2023
Revelation Pharma is a national network of 503A compounding pharmacies providing innovative and quality pharmacy preparations and services through “industry best” patient care and solutions for customers.
Our Exciting Vision
The compounding pharmacy industry is rapidly innovating and growing. Revelation Pharma will be a leader of that innovation and growth by bringing together top minds and talent in the industry to continue to leverage key insights and deliver top quality compounded drugs to meet patients’ exact needs. The team will seek to rekindle and harness much of the camaraderie and knowledge-sharing that has been a hallmark of the industry over the years
We believe the timing is ideal for a partnership to form and lead the compounding pharmacy industry into its next phase of growth. Partners joining the team will be able to participate in the vision and achieve much greater impact than as a standalone. They can achieve a near-term liquidity event and then also have the potential for a significant longer-term liquidity event
Join Our VisionSeller Benefits
Exit opportunity
Providing liquidity and personal financial diversification
Attractive ongoing investment
Opportunity to invest in and be part of a high-growth business
Collaboration
Innovate and share best practices with other industry leaders to develop and commercialize new treatments to improve patient’s quality of life
Cross-selling opportunities
Pursuing growth in new product segments across key markets
Best in class compliance program
Keen focus on addressing the increasing compliance burden through
- Capex investments to meet regulatory requirements
- Expert business, compliance, and legal teams to address any issues that arise
Inter-state distribution solution
Revelation Pharma will address challenges from new regulations (such as the FDA MOU) through a national team and streamlined protocols to manage changing regulations (i.e. certification, licensing, ect.)
Streamline back office operations
Modernized and efficient back office systems, including Regulatory, IT, HR, Accounting, Marketing, and Legal operations
Succession planning
Ensure seamless transition for aging owners looking to retire
Who We Are
Revelation is led by a team of industry-renowned experts, who have owned and grown their own respective compounding pharmacies. Management specializes in pharmaceutical innovation, mergers and acquisitions, organic service and geographic expansion, as well as regulation and compliance
Chairman
Jacob Beckel
President, M&A
Richard Case
Chief Executive Officer
Shawn Hodges
Chief Financial Officer
William Skinner
Chief Operating Officer
Jon Pritchett
SVP of Pharmacy Operations
Mitchell Bell
Criteria
The 503A compounding industry is highly fragmented, and Revelation Pharma plans to deploy an aggressive acquisition strategy to expand its national footprint to bring pharmacists closer to local communities across the country. The Revelation team is interested in partnering with 503A compounding pharmacy owners who have interest in selling a majority stake in their business, with opportunity for significant growth as part of a scalable, PE-backed platform
Operates as a 503A compounding pharmacy
Based in the USA
Compounding Revenue > $1.5 million and EBITDA > $250K
Frequently Asked Questions
-
How do you value my pharmacy?
- We are looking for the amount of cash flow that your company generates each year called EBITDA (Earnings Before Interest Taxes Depreciation Amortization) and then pay you a multiple of this based on current market conditions
- Most pharmacists run their business to minimize taxes. We understand this and make adjustments to EBITDA in your favor
- Our purchase price will be (Adjusted EBITDA x Multiple) = Purchase Price paid in cash. You can then decide how much you would like to roll into our equity
-
How can you grow my pharmacy business when I have been running it for the past 20 years?
- We take the administrative responsibility off your pharmacy and employees. We will do HR, IT, Regulatory etc..
- We will introduce other innovations and compounding opportunities that we are developing at a national level to your pharmacy
- We are developing an intercompany system that will provide compounding opportunities to your pharmacy from our partners in other states
-
How can you increase my Gross Margin?
- Better purchasing contracts with vendors
- Best in class operations to streamline your SOP’s and flow of business
-
I am doing well financially as a owner, why would I want to give that up?
- Cash in the bank (take some chips off the table)
- Roll equity (your stock) into our stock tax free
- Early investor opportunity – Would you have liked to invest in Walgreens when they had 100 locations?
-
I don’t ship much across state line so the MOU won’t affect me?
- We think it will be a positive item if you are receiving prescriptions from other pharmacies in our network
- If you are the first pharmacy location in your state to join us, you will have the best opportunity of capitalizing on growth from our innovative national products
-
I need capital to build out for the new USP 797 & 800. How do you do this?
- We will help you invest the capital that is needed to ensure your pharmacy meets our quality standards
- We also set up the training for your employees to become certified and maintain those standards
-
How long do I need to work for the company if I want to retire?
- Depending on where your desires lay, you can join us full-time or you can choose to retire. Most of our partners want somewhere in-between these options, and we can work with you to determine a solution that suits everyone
-
I would like to sell today for some cash but I have a few really good ideas on how to grow my business in the future and can show you how to do this nationwide. How does that work?
- We will pay you for the current value of your business today, and then build in incentives so that you can cash in on your ideas. In fact, we may provide you the resources needed to build a plan and implement your ideas
Our Financial Partner
Revelation Pharma has partnered with Osceola Capital to fund the growth of the business. Osceola operates a committed fund which provides Revelation Pharma the ability to deploy capital and execute transactions seamlessly
Osceola Capital is a respected Lower Middle Market private equity firm that specializes in investments in businesses with <$10M EBITDA, with a special focus in the healthcare services space
Osceola frequently invests and partners with founder owned/operated businesses, and the fund’s principals have spent significant time in operator roles. Osceola has the ability to provide resources to support the company’s operations as needed, but seeks to empower the management team to execute the strategy of the business
Where we’re going
- 2021
- 2022
- 2023
- Long Term
